LarotrectinibLack of efficacy following compassionate use: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1883卷 / 1期

关键词：

D O I：

10.1007/s40278-021-06176-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：221 / 221

相关论文

共 50 条

[41] Multiple drugsLack of efficacy following off-label use: 2 case reports
Reactions Weekly, 2022, 1907 (1) : 333 - 333
[42] Multiple drugsLack of efficacy following off-label use: 2 case reports
Reactions Weekly, 2021, 1872 (1) : 351 - 351
[43] Lopinavir/ritonavirLack of efficacy following off-label use: 2 case reports
Reactions Weekly, 2022, 1903 (1) : 225 - 225
[44] Dexamethasone/tocilizumab/tofacitinibLack of efficacy following off label use: 2 case reports
Reactions Weekly, 2022, 1894 (1) : 135 - 135
[45] Dabrafenib/trametinibVarious toxicities and compassionate use: 5 case reports
Reactions Weekly, 2025, 2056 (1) : 166 - 166
[46] COMPASSIONATE USE OF RANITIDINE - A REVIEW OF 210 CASE-REPORTS
HOLLAND, CE
HUSSEY, BK
ROGENES, PR
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1987, 41 (01): : 152 - 162
[47] Antibacterials/vasopressorsAcute renal failure, maculopapular rash and compassionate use: 2 case reports
Reactions Weekly, 2023, 1945 (1) : 60 - 60
[48] Multiple drugsLack of efficacy and compassionate use: case report
Reactions Weekly, 2025, 2050 (1) : 377 - 377
[49] DiazepamLack of efficacy following off label use: 12 case reports
Reactions Weekly, 2023, 1947 (1) : 154 - 154
[50] Multiple drugsLack of efficacy, and acute kidney injury following compassionate use of tisagenlecleucel: case report
Reactions Weekly, 2022, 1888 (1) : 256 - 256

← 1 2 3 4 5 →